Journal of Dental Pathology and Medicine
Open Access

Mucosal disorders; Oral lesions; Autoimmune diseases; Infections; Mucosal inflammation; Diagnosis; Treatment; Mucosal integrity

Mucosal membranes are thin layers of tissue that line the body's cavities and canals, including the respiratory system, gastrointestinal tract, mouth, and genital areas [1]. They serve essential functions in secretion, protection, and absorption, as well as in maintaining moisture and preventing infections [2]. When these membranes become damaged or inflamed, they may be affected by various mucosal disorders, leading to symptoms that disrupt normal bodily functions [3, 4].

Mucosal disorders can occur due to a wide variety of causes, including infections, autoimmune conditions, allergic reactions, trauma, and malignancies [5]. These disorders can affect a single mucosal site or multiple areas simultaneously, depending on the underlying condition [5]. As they can lead to pain, discomfort, and severe complications, understanding the causes, symptoms, and treatment options for mucosal disorders is essential for both patients and healthcare providers.

Types of mucosal disorders

Oral mucosal disorders

Oral mucosal disorders are conditions that affect the mucous lining inside the mouth. These include conditions like oral lichen planus, canker sores, and oral candidiasis, among others.

Canker sores are small, round or oval ulcers that develop inside the mouth, often on the inner lips, cheeks, tongue, or gums [6]. While the exact cause is unknown, factors such as stress, hormonal changes, and certain foods may trigger their development. Canker sores are often painful and can interfere with eating, speaking, and swallowing. They generally heal within one to two weeks.

Symptomatic treatment includes the use of over-the-counter topical treatments like corticosteroid creams or gels. Pain relief can be achieved with anesthetic mouth rinses.

Oral thrush is a fungal infection caused by the overgrowth of the Candida species, particularly Candida albicans, in the mouth [7]. It typically appears as white patches on the tongue, cheeks, and roof of the mouth. The infection is more common in individuals with compromised immune systems, such as those with HIV/AIDS, or in people using inhaled corticosteroids.

Antifungal treatments like nystatin or fluconazole are often prescribed to treat the infection. Maintaining good oral hygiene and managing underlying conditions is important to prevent recurrence.

Oral lichen planus is a chronic autoimmune condition that causes white, lacy patches or painful sores on the mucous membranes of the mouth [8]. It can be associated with systemic diseases such as hepatitis C.

Corticosteroid treatments, either topical or systemic, are commonly used to manage symptoms. In severe cases, other immunosuppressive drugs may be prescribed.

Autoimmune mucosal disorders

Autoimmune diseases are conditions in which the immune system mistakenly attacks the body’s own tissues. Several autoimmune disorders can affect the mucosal membranes, leading to chronic inflammation and tissue damage. Sjögren's syndrome is an autoimmune disorder that primarily affects the moisture-producing glands, including the salivary and lacrimal glands [9]. This leads to dry mouth (xerostomia) and dry eyes (keratoconjunctivitis sicca). The condition often causes discomfort, difficulty swallowing, and an increased risk of oral infections due to reduced saliva production. While there is no cure for Sjögren's syndrome, treatments focus on symptom management. Artificial saliva and saliva-stimulating medications like pilocarpine can help alleviate dry mouth. Immunosuppressive drugs may be used in cases with systemic involvement [10].

Pemphigus vulgaris is a rare autoimmune disorder that causes painful blisters and erosions in mucosal membranes, including the mouth and throat. The condition results from the body's immune system attacking the proteins that hold skin and mucosal cells together.

The treatment of pemphigus vulgaris involves systemic steroids and other immunosuppressive therapies to control inflammation and prevent blister formation.

Mucosal membranes are frequently involved in various infections, both viral and bacterial. These infections can lead to localized pain, lesions, and inflammation.

HSV infections cause painful, fluid-filled blisters that typically appear on the lips, mouth, or genital mucosa. The virus can cause recurrent outbreaks, especially when the immune system is weakened.

Antiviral medications, such as acyclovir, can help reduce the severity and duration of outbreaks. Topical creams and over-the-counter medications can help alleviate pain during flare-ups.

Certain strains of HPV can cause warts on the oral mucosa, particularly on the tongue and lips. While oral warts are typically benign, certain types of HPV are associated with an increased risk of oral and throat cancers.

Treatment may involve the removal of warts via surgical excision, laser therapy, or cryotherapy. Vaccination against HPV can help prevent the infection and its complications.

Trauma-induced mucosal disorders

Physical trauma or irritation can lead to mucosal disorders, particularly in the oral cavity. These conditions may arise from accidental bites, burns, or the chronic use of irritating substances.

Mucosal burns resulting from the ingestion of hot foods or contact with chemicals can cause painful lesions in the mouth. Chronic exposure to tobacco and alcohol can also irritate mucosal tissues.

Management includes avoiding further irritation and using topical corticosteroids to reduce inflammation. Pain relief can be achieved with anesthetic mouth rinses.

Contact stomatitis refers to inflammation of the mucosal membranes caused by allergens or irritants, such as dental materials, toothpaste, or certain foods. The condition often presents as red, inflamed areas or sores in the mouth.

Identifying and eliminating the irritant is crucial. Anti-inflammatory medications and corticosteroid ointments may help reduce symptoms.

Cancer that affects mucosal membranes is most commonly found in the oral cavity, nasopharynx, and esophagus. Oral cancers, particularly squamous cell carcinoma, are often linked to smoking, alcohol use, or HPV infection.

Symptoms of oral cancer include persistent sores that do not heal, unexplained lumps, difficulty swallowing, and changes in the voice. It is important to seek medical attention for any unusual changes in the mouth or throat.

Early-stage oral cancer is typically treated with surgical removal, possibly followed by radiation or chemotherapy, depending on the extent of the disease.

Diagnosis of mucosal disorders

The diagnosis of mucosal disorders often begins with a thorough medical history and clinical examination. A physical examination can reveal lesions, swelling, or other signs of mucosal damage. Additional diagnostic tools may include:

• To identify systemic conditions like autoimmune diseases.
• For suspected cancer or inflammatory conditions, a tissue sample may be taken for histological examination.
• In cases of suspected oral cancer or deep tissue involvement, imaging studies like CT scans or MRIs may be used.

Treatment of mucosal disorders

Treatment for mucosal disorders varies depending on the underlying cause. Options may include:

For conditions like canker sores or oral lichen planus, corticosteroid creams or gels may be prescribed.

For infections, antifungal, antiviral, or antibiotic treatments are used. For autoimmune conditions, immunosuppressive drugs may be necessary.

In cases of oral cancer or severe trauma, surgery may be required.

Artificial saliva for dry mouth or anesthetic treatments for pain relief may be helpful in managing chronic mucosal conditions.

Conclusion

Mucosal disorders are diverse and can significantly affect an individual’s quality of life, especially when they involve sensitive areas such as the mouth and genital regions. Timely diagnosis and appropriate treatment are essential for managing these disorders effectively. Healthcare providers must consider the wide range of possible causes for mucosal lesions and inflammation to offer the best treatment options, ensuring that patients receive comprehensive care and relief from symptoms. By increasing awareness of these conditions and providing access to early interventions, the impact of mucosal disorders on individuals can be minimized.

1. Tun KM, Imwong M, Lwin KM, Win AA, Hlaing TM, et al. (2015)Spread of artemisinin-resistantPlasmodium falciparumin Myanmar: a cross-sectional survey of the K13 molecular marker. THE LANCET Infectious Diseases 15: 415-421.

Indexed at, Google Scholar, Crossref

2. Akoria OA, Arhuidese IJ (2014) Progress toward elimination of malaria in Nigeria: Uptake of Artemisinin-based combination therapies for the treatment of malaria in households in Benin City. Annals of African medicine 13: 104-113

Indexed at, Google Scholar, Crossref

3. Baragan˜a B, Hallyburton I, Lee MCS, Norcross NR, Grimaldi R, et al. (2015)A novel multiple-stage antimalarial agent that inhibits protein synthesis. Nature 522: 315-320.

Indexed at, Google Scholar, Crossref

4. Exavery A, Mbaruku G, Mbuyita S, Makemba A, Kinyonge IP, et al. (2014) Factors affecting uptake of optimal doses of sulphadoxine-pyrimethamine for intermittent preventive treatment of malaria in pregnancy in six districts of Tanzania. Malaria Journal 13: 10-1186.

Indexed at, Google Scholar, Crossref

5. Simba DO, Kakoko D, Tomson G, Premji Z, Petzold M, et al. (2012)Adherence to artemether/lumefantrine treatment in children under real-life situations in rural Tanzania. Transactions of the Royal Society of Tropical Medicine and Hygiene 106: 3-9.

Indexed at, Google Scholar, Crossref

6. Bruxvoort K, Kalolella A, Cairns M, Festo C, Kenani M, et al. (2015) Are Tanzanian patients attending public facilities or private retailers more likely to adhere to artemisinin-based combination therapy? Malaria Journal 14: 1-12.

Indexed at, Google Scholar, Crossref

7. Win TZ, Zaw L, Khin W, Khin L, Tin OM, et al. (2012) Adherence to the recommended regimen of artemether-lumefantrine for treatment of uncomplicated falciparum malaria in Myanmar. Myanmar Health Science Research Journal 24: 51-55.

Indexed at, Google Scholar, Crossref

8. zbe OP, Mangham-Jefferies L, Cundill B, Wiseman V, Uzochukwu BS,et al. (2015) Quality of care for the treatment for uncomplicated malaria in South-East Nigeria: how important is socioeconomic status?. International Journal for Equity in Health 14: 19.

Indexed at, Google Scholar, Crossref

9. Watsierah CA, Jura WG, Oyugi H, Abong'o B, Ouma C (2010)Factors determining anti-malarial drug use in a peri-urban population from malaria holoendemic region of western Kenya. Malar J 9: 295.

Indexed at, Google Scholar, Crossref

10. Das A, Dash A (2007)Evolutionary paradigm of chloroquine-resistant malaria in India. Trends Parasito l23: 132-135.

Indexed at, Google Scholar, Crossref